CH₃CH₃
official

9-O-Demethylmitragynine (9-ODM): chemistry

by ch3ch3 · 8h ago · 0 comments

Structure

PubChem records the compound as “9-O-Demethylmitragynine”, CAS number “425623-55-8”, with “9-Hydroxycorynantheidine” as a synonym.⁠[1] Its formula is “C22H28N2O4” and its molecular weight “384.5 g/mol”.⁠[1] Mitragynine, the main kratom alkaloid, is “C23H30N2O4” at “398.5 g/mol”.⁠[2] The difference is one carbon and two hydrogens: a methyl group.

The two systematic names show where it comes off. Mitragynine's is “methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate”.⁠[2] 9-ODM's is “methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-hydroxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate”.⁠[1][2] The names are identical except for one word, methoxy against hydroxy: the methoxy group on the indole ring becomes a hydroxyl, and the stereochemistry is the same.⁠[1][2]

Two numbering systems, three names

Alkaloid chemists number that ring position 9, which gives the names 9-O-demethylmitragynine and 9-hydroxycorynantheidine.⁠[1] The systematic name numbers the same position 8 (“8-hydroxy”).⁠[1] Florida's emergency rule of July 2026 listed the compound as “9-Hydroxycorynantheidine (9-O-Demethylmitragynine, 8-OH)”, using both.⁠[3] All of these name one compound. Pack names such as MIT-9 and C9 are not chemical names and do not identify a compound; the general section explains why.

How it is made

It can be made from mitragynine in the laboratory: the 2006 study that first tested it on opioid receptors noted that it “is synthesized from mitragynine”.⁠[4] No published source was found describing how the compound in commercial tablets is made.

The body makes it too. Testing individual human liver enzymes, a 2020 study reported that “9-O-demethylmitragynine, the most abundant metabolite in vitro (and the most prevalent metabolite in urine among kratom users) was produced by 2C19, 3A4 and 2D6”.⁠[5] By comparison, 7-hydroxymitragynine “was produced exclusively by 3A4”.⁠[5] A 2024 study with human liver fractions found that “9-O-demethylmitragynine is a major metabolite formed from mitragynine metabolism (36 % total metabolism) and displays similar pharmacologic activity”.⁠[6] In rats given mitragynine by mouth, “the major metabolites were mitragynine acid and 9-hydroxycorynantheidine”.⁠[7]

In blood and urine

In urine from cases involving kratom, “9-O-Demethylmitragynine and 7-hydroxymitragynine were identified in unhydrolyzed urine in 75% and 63% of the cases”.⁠[8] In plasma from regular kratom users, a 2026 method paper found “mitragynine 16-carboxylic acid and 9-hydroxycorynantheidine being the major circulating metabolites of mitragynine in plasma upon kratom oral administration”.⁠[9] A practical consequence: a positive urine or blood test for 9-ODM does not show that someone took a 9-ODM product, because kratom itself produces it.⁠[5][9]

Stability

The same paper had to treat it as fragile: “Chemically unstable metabolites, 7-hydroxymitragynine and 9-hydroxycorynantheidine, were stabilized in human plasma”.⁠[9] That finding is about blood samples. How the compound keeps in a tablet on a shelf has not been published.⁠[9]

References

  1. 9-O-Demethylmitragynine, PubChem compound record CID 10927114 — National Center for Biotechnology Information, PubChem
  2. Mitragynine, PubChem compound record CID 3034396 — National Center for Biotechnology Information, PubChem
  3. Rule 2ER26-1 (emergency rule), Florida Department of Legal Affairs (Wayback Machine copy of the rule page) — Florida Department of State, Florida Administrative Code
  4. Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum (Matsumoto et al., Life Sciences 2006) — PubMed (US National Library of Medicine)
  5. CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine (Basiliere and Kerrigan, Journal of Analytical Toxicology 2020) — PubMed (US National Library of Medicine)
  6. An in vitro evaluation on metabolism of mitragynine to 9-O-demethylmitragynine (Melchert, Zhang and Markowitz, Chemico-Biological Interactions 2024) — PubMed (US National Library of Medicine)
  7. Multiple-Dose Pharmacokinetics and Safety of Mitragynine, the Major Alkaloid of Kratom, in Rats (Chiang et al., ACS Pharmacology and Translational Science 2024) — PubMed (US National Library of Medicine)
  8. Identification of metabolites and potential biomarkers of kratom in urine (Basiliere and Kerrigan, Journal of Chromatography B 2020) — PubMed (US National Library of Medicine)
  9. Simultaneous quantification of seventeen kratom alkaloids and metabolites in human plasma and its application to clinical pharmacokinetic sample analysis (Kanumuri et al., Pharmaceutical Biology 2026) — PubMed (US National Library of Medicine)
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something